Cancer Navigation Platform (Cancer Moonshot)

癌症导航平台（癌症登月）

• 批准号: 10714603
• 负责人: ANDREW ARCHER
• 金额: $ 198.82万
• 依托单位: BROAD AXE CARE COORDINATION LLC D/B/A LOCUS HEALTH
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-19 至 2024-09-18
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10714603
• 关键词: Address; Adherence; Area; Bluetooth; Cancer Center; Cancer Patient; Caring; Clinical; Communication; Contracts; Data; Development; Distress; Enrollment; Evaluation; Feedback; Funding; Goals; Health; Health Insurance Portability and Accountability Act; Health system; Institutes; Interview; Malignant Neoplasms; Methodology; Monitor; Patient Education; Patient Schedules; Patient-Focused Outcomes; Patients; Phase; Privacy; Provider; Reporting; Research Training; Resources; Risk; Schedule; Secure; Security; Site; Social support; Testing; Thermometers; University of Virginia Cancer Center; Update; base; cancer diagnosis; care coordination; commercialization; dashboard; data visualization; design; handheld mobile device; improved; insight; interoperability; meetings; member; patient engagement; phase 1 testing; programs; prototype; recruit; social health determinants; tool; usability

Locus Health, in this Phase II effort, will further develop and demonstrate the utility and commercial viability of its scalable, HIPAA-compliant Cancer Navigation Platform. The long-term goals of this Platform are to improve cancer patient outcomes and the efficiency and quality of patient navigation. Building on Phase I results, the project team will further develop the Platform’s patient engagement and navigation capabilities that promote targeted patient education, communication with patients and among the care team, care coordination including effective two-way integration with the EMR, patient scheduling, and resource access and referrals, with particular emphasis placed on support for Social Determinants of Health. The project will test patient engagement, adherence, navigator efficiency, and key patient outcomes by initiating pilot implementations at two sites, Inova Schar Cancer Institute and the University of Virginia Cancer Center. At the end of these pilots, parallel usability studies will be conducted at both sites to test key aspects of the patient, navigator, and integration capabilities to provide specific feedback for a further development cycle. In addition to commercializing the Platform at the two sites, the team expects to also secure 2-3 additional commercial commitments at leading Cancer Centers/Health Systems. (Funded by Cancer Moonshot)

在第二阶段的努力中，Locus Health将进一步开发和展示其实用性和商业可行性。 可扩展、符合HIPAA的癌症导航平台。该平台的长期目标是改善癌症 患者结局以及患者导航的效率和质量。在第一阶段成果的基础上，项目小组将 进一步开发平台的患者参与和导航功能，以促进有针对性的患者教育， 与患者和护理团队之间的沟通，护理协调，包括有效的双向整合， EMR、患者调度、资源访问和转诊，特别强调对社会 健康的决定因素。该项目将测试患者参与度、依从性、导航效率和关键患者 通过在Inova Schar癌症研究所和弗吉尼亚大学这两个地点启动试点实施， 癌症中心在这些试点结束时，将在两个地点进行平行的可用性研究，以测试 患者、导航器和集成功能，为进一步的开发周期提供特定的反馈。在 除了在这两个地点将平台商业化之外，该团队还希望获得2-3个额外的商业 主要癌症中心/卫生系统的承诺。（图片来源：Cancer Moonshot）